Kossan Rubber Industries Bhd

KLSE:KOSSAN Stock Report

Market Cap: RM 6.3b

Kossan Rubber Industries Bhd Valuation

Is KOSSAN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of KOSSAN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: KOSSAN (MYR2.45) is trading above our estimate of fair value (MYR1.4)

Significantly Below Fair Value: KOSSAN is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for KOSSAN?

Key metric: As KOSSAN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for KOSSAN. This is calculated by dividing KOSSAN's market cap by their current earnings.
What is KOSSAN's PE Ratio?
PE Ratio67.8x
EarningsRM 92.25m
Market CapRM 6.25b

Price to Earnings Ratio vs Peers

How does KOSSAN's PE Ratio compare to its peers?

The above table shows the PE ratio for KOSSAN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average64.2x
HARTA Hartalega Holdings Berhad
154.8x53.3%RM 12.0b
AP4 Riverstone Holdings
17.8x9.8%S$1.5b
KPJ KPJ Healthcare Berhad
36.1x11.4%RM 10.8b
688289 Sansure Biotech
48x34.2%CN¥12.6b
KOSSAN Kossan Rubber Industries Bhd
67.8x35.2%RM 6.3b

Price-To-Earnings vs Peers: KOSSAN is expensive based on its Price-To-Earnings Ratio (67.8x) compared to the peer average (64.3x).

Price to Earnings Ratio vs Industry

How does KOSSAN's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
KOSSAN 67.8xIndustry Avg. 25.9xNo. of Companies47PE020406080100+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: KOSSAN is expensive based on its Price-To-Earnings Ratio (67.8x) compared to the Asian Medical Equipment industry average (25.8x).

Price to Earnings Ratio vs Fair Ratio

What is KOSSAN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

KOSSAN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio67.8x
Fair PE Ratio51.5x

Price-To-Earnings vs Fair Ratio: KOSSAN is expensive based on its Price-To-Earnings Ratio (67.8x) compared to the estimated Fair Price-To-Earnings Ratio (51.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst KOSSAN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentRM 2.45
RM 2.46
+0.3%
15.7%RM 3.10RM 1.80n/a16
Nov ’25RM 2.14
RM 2.26
+5.4%
15.9%RM 3.00RM 1.60n/a16
Oct ’25RM 1.96
RM 2.23
+13.6%
19.5%RM 3.10RM 1.56n/a16
Sep ’25RM 1.82
RM 2.23
+22.3%
19.5%RM 3.10RM 1.56n/a16
Aug ’25RM 2.09
RM 2.37
+13.2%
19.7%RM 3.23RM 1.48n/a16
Jul ’25RM 2.40
RM 2.37
-1.1%
19.8%RM 3.23RM 1.48n/a16
Jun ’25RM 2.22
RM 2.32
+4.4%
22.4%RM 3.23RM 1.48n/a16
May ’25RM 2.20
RM 1.87
-15.1%
19.2%RM 2.40RM 1.33n/a16
Apr ’25RM 1.95
RM 1.86
-4.8%
18.5%RM 2.35RM 1.33n/a16
Mar ’25RM 1.89
RM 1.86
-1.8%
18.5%RM 2.35RM 1.33n/a16
Feb ’25RM 2.05
RM 1.64
-20.2%
22.7%RM 2.30RM 1.23n/a16
Jan ’25RM 1.85
RM 1.54
-16.6%
23.0%RM 2.30RM 1.00n/a17
Dec ’24RM 1.69
RM 1.41
-16.6%
13.3%RM 1.75RM 1.00n/a16
Nov ’24RM 1.35
RM 1.20
-10.8%
17.3%RM 1.60RM 0.88RM 2.1416
Oct ’24RM 1.32
RM 1.20
-8.8%
17.3%RM 1.60RM 0.88RM 1.9616
Sep ’24RM 1.32
RM 1.20
-9.2%
17.0%RM 1.60RM 0.88RM 1.8217
Aug ’24RM 1.41
RM 1.20
-15.0%
17.0%RM 1.60RM 0.88RM 2.0917
Jul ’24RM 1.29
RM 1.12
-13.2%
17.8%RM 1.42RM 0.83RM 2.4017
Jun ’24RM 1.46
RM 1.12
-23.3%
17.8%RM 1.42RM 0.83RM 2.2217
May ’24RM 1.25
RM 1.12
-10.6%
17.7%RM 1.42RM 0.83RM 2.2017
Apr ’24RM 1.31
RM 1.12
-14.3%
23.9%RM 1.90RM 0.78RM 1.9518
Mar ’24RM 1.07
RM 1.09
+1.5%
23.0%RM 1.90RM 0.78RM 1.8918
Feb ’24RM 1.05
RM 1.15
+9.3%
22.8%RM 1.90RM 0.75RM 2.0518
Jan ’24RM 1.10
RM 1.18
+7.3%
20.8%RM 1.90RM 0.85RM 1.8518
Dec ’23RM 1.09
RM 1.18
+8.3%
20.8%RM 1.90RM 0.85RM 1.6918
Nov ’23RM 1.21
RM 1.29
+6.5%
18.2%RM 1.90RM 0.85RM 1.3518

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies